2Lubitz CC, Kong CY, McMahon PM, et al . Annual financial impact of well-differentiated thyroid cancer care in the United States[J]. Cancer, 2014,120(9) ~ 1345-1352.
3Mehra S,Tuttle RM,Bergman D, et al .Improving the quality of thyroid cancer care~ How does the thyroid cancer care col laborative cross the institute of medicine's quality chasm[J]. Thyroid, 2014,24(4) ~615-624.
4Haymart MR, Banerjee M, Yang D, et al . The relationship between extent of thyroid cancer surgery and use of radioac- tive iodine[J]. Ann Surg, 2013,258(2) ~ 354-358.
5Occupational rate of RI treatment room for therapy of thyroid cancer for patients taking iodine radioisotopes ~-J~. Kaku Igaku, 2014, 51(4)~ 387 394.
6Xu G, Wu T, Ge L, et al . A systematic review of adjuvant interventions for radioiodine in patients with thyroid cancer [J]. Oncol Res Treat, 2015, 38(7-8) ~ 368-372.
7Hadjisavva IS, Dina R, Talias MA, et al. Prevalence of cancer in patients with thyroid nodules in the Island of Cy prus: predictive value of ultrasound features and thyroid au- toimmune status[J]. Eur Thyroid J, 2015, 4(2) = 123 128.
8Worden F, Fassnacht M, Shi Y, et al . Safety and tolerabili- ty of sorafenib in patients with radioiodine refractory thyroid eancerFJ~. Endocr Relat Cancer, 2015, 22(6) : 877-887.
